Sanofi SA (NASDAQ:SNY)

52.65
Delayed Data
As of Jun 29
 +0.53 / +1.02%
Today’s Change
46.93
Today|||52-Week Range
58.10
+5.09%
Year-to-Date
Investors Need Not Be Alarmed by Drug Patent Expirations
Jun 28 / GuruFocus News - Paid Partner Content
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Jun 25 / MotleyFool.com - Paid Partner Content
Sanofi (SNY) Wins Nod for Nexviadyme & Xenpozyme in Europe
Jun 28 / Zacks.com - Paid Partner Content
Why Sanofi May Be a Frontrunner in Endemic COVID-19
Jun 25 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close52.14
Today’s open52.63
Day’s range52.45 - 52.88
Volume1,813,854
Average volume (3 months)2,233,940
Market cap$134.0B
Data as of 5:09pm ET, 06/29/2022

Growth & Valuation

Earnings growth (last year)-47.56%
Earnings growth (this year)-96.15%
Earnings growth (next 5 years)+8.75%
Revenue growth (last year)+8.63%
P/E ratio20.4
Price/Sales2.82
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.01-0.02%
BMYBristol-Myers Squibb-0.01-0.01%
ZTSZoetis Inc+3.80+2.23%
----
Data as of 7:29pm ET, 06/29/2022

Financials

Last reporting date--
EPS forecast (this quarter)$0.70
Annual revenue (last year)$44.6B
Annual profit (last year)$7.4B
Net profit margin16.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Paris, Ile-de-france

Forecasts